_id
6915f08dbc934aba376b1ffe
Ticker
ROIV
Name
Roivant Sciences Ltd
Exchange
NASDAQ
Address
11-12 St. James's Square, London, United Kingdom, SW1Y 4LB
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://roivant.com
Description
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Last Close
21.34
Volume
5033605
Current Price
22.1
Change
3.561387066541713
Last Updated
2025-12-03T13:04:45.357Z
Image
data:image/webp;base64,UklGRqQAAABXRUJQVlA4IJgAAAAwBgCdASpAAEAAPrVMoEonJCMhsfcYAOAWiWMA09g9sOWiqJjhimrYbS1jLkFnmS0EqFt6a+oRDzHgAP73jBO5aO+M4+uayW8+6caYsgb+hk5YFKd3Gcn43sZ+uYmjMwYo/7HXkS/FTkx+usF8sLMFaXf4u0A3q7ubtEb5SUE3d63mBWXZCCKh11wRvY9xWSSBuYPoIEQgAA==
Ipo Date
2021-10-01T00:00:00.000Z
Market Cap
13979380736
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9254823529411764
Sentiment Sources
17
Rating
4.5
Target Price
24.5455
Strong Buy
6
Buy
3
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1571000
Cost Of Revenue
111000
Gross Profit
1460000
Operating Expenses
307693000
Operating Income
-306233000
Interest Expense
-
Pretax Income
-159044000
Net Income
-113519000
Eps
-0.16670732910410502
Dividends Per Share
-
Shares Outstanding
695491615
Income Tax Expense
6995000
EBITDA
-158122000
Operating Margin
-19492.8707829408
Total Other Income Expense Net
147189000
Cash
1237010000
Short Term Investments
3148825000
Receivables
-
Inventories
-
Total Current Assets
4511646000
Property Plant Equipment
110803000
Total Assets
5062598000
Payables
15064000
Short Term Debt
9002000
Long Term Debt
-
Total Liabilities
257140000
Equity
4362331000
Depreciation
921000
Change In Working Capital
7075000
Cash From Operations
-185664000
Capital Expenditures
7848000
Cash From Investing
120422000
Cash From Financing
62587000
Net Change In Cash
-1449000
PE
-
PB
3.4497491911090656
ROE
-2.6022555372345657
ROA
-2.2423072106456012
FCF
-193512000
Fcf Percent
-123.17759388924252
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1571000
Quarters > 0 > income Statement > cost Of Revenue
111000
Quarters > 0 > income Statement > gross Profit
1460000
Quarters > 0 > income Statement > operating Expenses
307693000
Quarters > 0 > income Statement > operating Income
-306233000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-159044000
Quarters > 0 > income Statement > net Income
-113519000
Quarters > 0 > income Statement > eps
-0.16670732910410502
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
680947866
Quarters > 0 > income Statement > income Tax Expense
6995000
Quarters > 0 > income Statement > EBITDA
-158122000
Quarters > 0 > income Statement > operating Margin
-19492.8707829408
Quarters > 0 > income Statement > total Other Income Expense Net
147189000
Quarters > 0 > balance Sheet > cash
1237010000
Quarters > 0 > balance Sheet > short Term Investments
3148825000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4511646000
Quarters > 0 > balance Sheet > property Plant Equipment
110803000
Quarters > 0 > balance Sheet > total Assets
5062598000
Quarters > 0 > balance Sheet > payables
15064000
Quarters > 0 > balance Sheet > short Term Debt
9002000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
257140000
Quarters > 0 > balance Sheet > equity
4362331000
Quarters > 0 > cash Flow > net Income
-113519000
Quarters > 0 > cash Flow > depreciation
921000
Quarters > 0 > cash Flow > change In Working Capital
7075000
Quarters > 0 > cash Flow > cash From Operations
-185664000
Quarters > 0 > cash Flow > capital Expenditures
7848000
Quarters > 0 > cash Flow > cash From Investing
120422000
Quarters > 0 > cash Flow > cash From Financing
62587000
Quarters > 0 > cash Flow > net Change In Cash
-1449000
Quarters > 0 > ratios > PE
-0.16670732910410502
Quarters > 0 > ratios > PB
3.4497491911090656
Quarters > 0 > ratios > ROE
-2.6022555372345657
Quarters > 0 > ratios > ROA
-2.2423072106456012
Quarters > 0 > ratios > FCF
-193512000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-123.17759388924252
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
2170000
Quarters > 1 > income Statement > cost Of Revenue
154000
Quarters > 1 > income Statement > gross Profit
2016000
Quarters > 1 > income Statement > operating Expenses
286938000
Quarters > 1 > income Statement > operating Income
-284922000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-269262000
Quarters > 1 > income Statement > net Income
-223355000
Quarters > 1 > income Statement > eps
-0.32832470061801367
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
680286922
Quarters > 1 > income Statement > income Tax Expense
4649000
Quarters > 1 > income Statement > EBITDA
-283824000
Quarters > 1 > income Statement > operating Margin
-13130.04608294931
Quarters > 1 > income Statement > total Other Income Expense Net
15660000
Quarters > 1 > balance Sheet > cash
1238459000
Quarters > 1 > balance Sheet > short Term Investments
3264692000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4615751000
Quarters > 1 > balance Sheet > property Plant Equipment
101943000
Quarters > 1 > balance Sheet > total Assets
5032602000
Quarters > 1 > balance Sheet > payables
11550000
Quarters > 1 > balance Sheet > short Term Debt
9402000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
216696000
Quarters > 1 > balance Sheet > equity
4345634000
Quarters > 1 > cash Flow > net Income
-273911000
Quarters > 1 > cash Flow > depreciation
1098000
Quarters > 1 > cash Flow > change In Working Capital
-37166000
Quarters > 1 > cash Flow > cash From Operations
-204383000
Quarters > 1 > cash Flow > capital Expenditures
4035000
Quarters > 1 > cash Flow > cash From Investing
-1085716000
Quarters > 1 > cash Flow > cash From Financing
-187768000
Quarters > 1 > cash Flow > net Change In Cash
-1477052000
Quarters > 1 > ratios > PE
-0.32832470061801367
Quarters > 1 > ratios > PB
3.4596427071861093
Quarters > 1 > ratios > ROE
-5.139756362362776
Quarters > 1 > ratios > ROA
-4.438161412327063
Quarters > 1 > ratios > FCF
-208418000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-96.04516129032258
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7570000
Quarters > 2 > income Statement > cost Of Revenue
205000
Quarters > 2 > income Statement > gross Profit
7365000
Quarters > 2 > income Statement > operating Expenses
292330000
Quarters > 2 > income Statement > operating Income
-284965000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-203054000
Quarters > 2 > income Statement > net Income
-206475000
Quarters > 2 > income Statement > eps
-0.2919203901037609
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
707299000
Quarters > 2 > income Statement > income Tax Expense
49321000
Quarters > 2 > income Statement > EBITDA
-283540000
Quarters > 2 > income Statement > operating Margin
-3764.3989431968294
Quarters > 2 > income Statement > total Other Income Expense Net
81911000
Quarters > 2 > balance Sheet > cash
2715411000
Quarters > 2 > balance Sheet > short Term Investments
2171480000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5000064000
Quarters > 2 > balance Sheet > property Plant Equipment
101077000
Quarters > 2 > balance Sheet > total Assets
5436940000
Quarters > 2 > balance Sheet > payables
23691000
Quarters > 2 > balance Sheet > short Term Debt
9842000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
249742000
Quarters > 2 > balance Sheet > equity
4687605000
Quarters > 2 > cash Flow > net Income
-252375000
Quarters > 2 > cash Flow > depreciation
1425000
Quarters > 2 > cash Flow > change In Working Capital
34484000
Quarters > 2 > cash Flow > cash From Operations
-172565000
Quarters > 2 > cash Flow > capital Expenditures
811000
Quarters > 2 > cash Flow > cash From Investing
1074194000
Quarters > 2 > cash Flow > cash From Financing
-177153000
Quarters > 2 > cash Flow > net Change In Cash
723987000
Quarters > 2 > ratios > PE
-0.2919203901037609
Quarters > 2 > ratios > PB
3.33460432352982
Quarters > 2 > ratios > ROE
-4.404701334690103
Quarters > 2 > ratios > ROA
-3.797632491806053
Quarters > 2 > ratios > FCF
-173376000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-22.903038309114926
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
9018000
Quarters > 3 > income Statement > cost Of Revenue
259000
Quarters > 3 > income Statement > gross Profit
8759000
Quarters > 3 > income Statement > operating Expenses
283140000
Quarters > 3 > income Statement > operating Income
-274381000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-234513000
Quarters > 3 > income Statement > net Income
169381000
Quarters > 3 > income Statement > eps
0.23436730333907094
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
722716000
Quarters > 3 > income Statement > income Tax Expense
-25568000
Quarters > 3 > income Statement > EBITDA
-271460000
Quarters > 3 > income Statement > operating Margin
-3042.5925925925926
Quarters > 3 > income Statement > total Other Income Expense Net
39868000
Quarters > 3 > balance Sheet > cash
1990683000
Quarters > 3 > balance Sheet > short Term Investments
3155825000
Quarters > 3 > balance Sheet > receivables
143781000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5363968000
Quarters > 3 > balance Sheet > property Plant Equipment
104458000
Quarters > 3 > balance Sheet > total Assets
5792345000
Quarters > 3 > balance Sheet > payables
23712000
Quarters > 3 > balance Sheet > short Term Debt
9835000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
256375000
Quarters > 3 > balance Sheet > equity
5189472000
Quarters > 3 > cash Flow > net Income
118075000
Quarters > 3 > cash Flow > depreciation
2921000
Quarters > 3 > cash Flow > change In Working Capital
-53105000
Quarters > 3 > cash Flow > cash From Operations
-207251000
Quarters > 3 > cash Flow > capital Expenditures
1827000
Quarters > 3 > cash Flow > cash From Investing
454074000
Quarters > 3 > cash Flow > cash From Financing
-272951000
Quarters > 3 > cash Flow > net Change In Cash
-27195000
Quarters > 3 > ratios > PE
0.23436730333907094
Quarters > 3 > ratios > PB
3.0777743092168146
Quarters > 3 > ratios > ROE
3.263935136368401
Quarters > 3 > ratios > ROA
2.9242215372185187
Quarters > 3 > ratios > FCF
-209078000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-23.184519849190508
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
29053000
Annuals > 0 > income Statement > cost Of Revenue
911000
Annuals > 0 > income Statement > gross Profit
28142000
Annuals > 0 > income Statement > operating Expenses
1031436000
Annuals > 0 > income Statement > operating Income
-1003294000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-681590000
Annuals > 0 > income Statement > net Income
-171981000
Annuals > 0 > income Statement > eps
-0.2370856745832621
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
725396000
Annuals > 0 > income Statement > income Tax Expense
48174000
Annuals > 0 > income Statement > EBITDA
-1099610000
Annuals > 0 > income Statement > operating Margin
-3453.3232368430113
Annuals > 0 > income Statement > total Other Income Expense Net
321704000
Annuals > 0 > balance Sheet > cash
2715411000
Annuals > 0 > balance Sheet > short Term Investments
2171480000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5000064000
Annuals > 0 > balance Sheet > property Plant Equipment
101077000
Annuals > 0 > balance Sheet > total Assets
5436940000
Annuals > 0 > balance Sheet > payables
23691000
Annuals > 0 > balance Sheet > short Term Debt
9842000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
249742000
Annuals > 0 > balance Sheet > equity
4687605000
Annuals > 0 > cash Flow > net Income
-356734000
Annuals > 0 > cash Flow > depreciation
14071000
Annuals > 0 > cash Flow > change In Working Capital
-77046000
Annuals > 0 > cash Flow > cash From Operations
-839451000
Annuals > 0 > cash Flow > capital Expenditures
4599000
Annuals > 0 > cash Flow > cash From Investing
-1766291000
Annuals > 0 > cash Flow > cash From Financing
-1219794000
Annuals > 0 > cash Flow > net Change In Cash
-3824789000
Annuals > 0 > ratios > PE
-0.2370856745832621
Annuals > 0 > ratios > PB
3.110428374404414
Annuals > 0 > ratios > ROE
-3.6688458178536805
Annuals > 0 > ratios > ROA
-3.1631947382167174
Annuals > 0 > ratios > FCF
-844050000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-29.052077238150964
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
32713000
Annuals > 1 > income Statement > cost Of Revenue
1599000
Annuals > 1 > income Statement > gross Profit
31114000
Annuals > 1 > income Statement > operating Expenses
-4465918000
Annuals > 1 > income Statement > operating Income
4497032000
Annuals > 1 > income Statement > interest Expense
34778000
Annuals > 1 > income Statement > pretax Income
4567856000
Annuals > 1 > income Statement > net Income
4348926000
Annuals > 1 > income Statement > eps
5.23305325741846
Annuals > 1 > income Statement > dividends Per Share
6000000
Annuals > 1 > income Statement > shares Outstanding
831049444
Annuals > 1 > income Statement > income Tax Expense
21503000
Annuals > 1 > income Statement > EBITDA
-802892000
Annuals > 1 > income Statement > operating Margin
13746.926298413477
Annuals > 1 > income Statement > total Other Income Expense Net
70824000
Annuals > 1 > balance Sheet > cash
6535706000
Annuals > 1 > balance Sheet > short Term Investments
5367000
Annuals > 1 > balance Sheet > receivables
82813000
Annuals > 1 > balance Sheet > inventories
35251000
Annuals > 1 > balance Sheet > total Current Assets
6731828000
Annuals > 1 > balance Sheet > property Plant Equipment
65950000
Annuals > 1 > balance Sheet > total Assets
7222482000
Annuals > 1 > balance Sheet > payables
53225000
Annuals > 1 > balance Sheet > short Term Debt
21893000
Annuals > 1 > balance Sheet > long Term Debt
430591000
Annuals > 1 > balance Sheet > total Liabilities
773953000
Annuals > 1 > balance Sheet > equity
5968581000
Annuals > 1 > cash Flow > net Income
4231206000
Annuals > 1 > cash Flow > depreciation
22036000
Annuals > 1 > cash Flow > change In Working Capital
19035000
Annuals > 1 > cash Flow > cash From Operations
-765268000
Annuals > 1 > cash Flow > capital Expenditures
1382000
Annuals > 1 > cash Flow > cash From Investing
5203623000
Annuals > 1 > cash Flow > cash From Financing
419364000
Annuals > 1 > cash Flow > net Change In Cash
4858335000
Annuals > 1 > ratios > PE
5.23305325741846
Annuals > 1 > ratios > PB
2.7986708774497657
Annuals > 1 > ratios > ROE
72.863650505874
Annuals > 1 > ratios > ROA
60.21373261989438
Annuals > 1 > ratios > FCF
-766650000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-23.43563720844924
Annuals > 1 > health Score
74
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
61280000
Annuals > 2 > income Statement > cost Of Revenue
13128000
Annuals > 2 > income Statement > gross Profit
48152000
Annuals > 2 > income Statement > operating Expenses
1223470000
Annuals > 2 > income Statement > operating Income
-1175318000
Annuals > 2 > income Statement > interest Expense
27968000
Annuals > 2 > income Statement > pretax Income
-1224834000
Annuals > 2 > income Statement > net Income
-1009030000
Annuals > 2 > income Statement > eps
-1.415604065154488
Annuals > 2 > income Statement > dividends Per Share
162713000
Annuals > 2 > income Statement > shares Outstanding
712791115
Annuals > 2 > income Statement > income Tax Expense
5190000
Annuals > 2 > income Statement > EBITDA
-1178009000
Annuals > 2 > income Statement > operating Margin
-1917.9471279373367
Annuals > 2 > income Statement > total Other Income Expense Net
-49516000
Annuals > 2 > balance Sheet > cash
1676813000
Annuals > 2 > balance Sheet > short Term Investments
5011000
Annuals > 2 > balance Sheet > receivables
37644000
Annuals > 2 > balance Sheet > inventories
2761000
Annuals > 2 > balance Sheet > total Current Assets
1798587000
Annuals > 2 > balance Sheet > property Plant Equipment
92337000
Annuals > 2 > balance Sheet > total Assets
2389604000
Annuals > 2 > balance Sheet > payables
37830000
Annuals > 2 > balance Sheet > short Term Debt
52413000
Annuals > 2 > balance Sheet > long Term Debt
375515000
Annuals > 2 > balance Sheet > total Liabilities
782017000
Annuals > 2 > balance Sheet > equity
1157766000
Annuals > 2 > cash Flow > net Income
-1115463000
Annuals > 2 > cash Flow > depreciation
18857000
Annuals > 2 > cash Flow > change In Working Capital
6345000
Annuals > 2 > cash Flow > cash From Operations
-843393000
Annuals > 2 > cash Flow > capital Expenditures
12690000
Annuals > 2 > cash Flow > cash From Investing
-44269000
Annuals > 2 > cash Flow > cash From Financing
499462000
Annuals > 2 > cash Flow > net Change In Cash
-381919000
Annuals > 2 > ratios > PE
-1.415604065154488
Annuals > 2 > ratios > PB
12.374781615196854
Annuals > 2 > ratios > ROE
-87.15318985010788
Annuals > 2 > ratios > ROA
-42.22582486470562
Annuals > 2 > ratios > FCF
-856083000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-13.970022845953002
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
55286000
Annuals > 3 > income Statement > cost Of Revenue
8966000
Annuals > 3 > income Statement > gross Profit
46320000
Annuals > 3 > income Statement > operating Expenses
1397962000
Annuals > 3 > income Statement > operating Income
-1351642000
Annuals > 3 > income Statement > interest Expense
7041000
Annuals > 3 > income Statement > pretax Income
-923747000
Annuals > 3 > income Statement > net Income
-845262000
Annuals > 3 > income Statement > eps
-1.2620494749278324
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
669753458
Annuals > 3 > income Statement > income Tax Expense
369000
Annuals > 3 > income Statement > EBITDA
-910774000
Annuals > 3 > income Statement > operating Margin
-2444.817856238469
Annuals > 3 > income Statement > total Other Income Expense Net
427895000
Annuals > 3 > balance Sheet > cash
2060400000
Annuals > 3 > balance Sheet > short Term Investments
13634000
Annuals > 3 > balance Sheet > receivables
6732000
Annuals > 3 > balance Sheet > inventories
-16463000
Annuals > 3 > balance Sheet > total Current Assets
2146523000
Annuals > 3 > balance Sheet > property Plant Equipment
86949000
Annuals > 3 > balance Sheet > total Assets
2585129000
Annuals > 3 > balance Sheet > payables
34583000
Annuals > 3 > balance Sheet > short Term Debt
11398000
Annuals > 3 > balance Sheet > long Term Debt
210025000
Annuals > 3 > balance Sheet > total Liabilities
523695000
Annuals > 3 > balance Sheet > equity
1656944000
Annuals > 3 > cash Flow > net Income
-924116000
Annuals > 3 > cash Flow > depreciation
5932000
Annuals > 3 > cash Flow > change In Working Capital
15719000
Annuals > 3 > cash Flow > cash From Operations
-677729000
Annuals > 3 > cash Flow > capital Expenditures
17436000
Annuals > 3 > cash Flow > cash From Investing
303295000
Annuals > 3 > cash Flow > cash From Financing
306792000
Annuals > 3 > cash Flow > net Change In Cash
-67642000
Annuals > 3 > ratios > PE
-1.2620494749278324
Annuals > 3 > ratios > PB
8.124622501303605
Annuals > 3 > ratios > ROE
-51.01331125252272
Annuals > 3 > ratios > ROA
-32.69709171186428
Annuals > 3 > ratios > FCF
-695165000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-12.57397894584524
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.16670732910410502
Valuation > metrics > PB
3.4497491911090656
Valuation > final Score
45.502508088909345
Valuation > verdict
15.0% Overvalued
Profitability > metrics > ROE
-2.6022555372345657
Profitability > metrics > ROA
-2.51613269303487
Profitability > metrics > Net Margin
-72.25907065563335
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05894554998233743
Risk > metrics > Interest Coverage
-332.1399132321041
Risk > final Score
-1269
Risk > verdict
High
Liquidity > metrics > Current Ratio
187.46970830216904
Liquidity > metrics > Quick Ratio
187.46970830216904
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
45.40357292813891
Prev Valuations > 1
46.6539567647018
Prev Valuations > 2
69.22225690783185
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
46
Prev Risks > 0
-18
Prev Risks > 1
46
Prev Risks > 2
30
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:07:13.736Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-16
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.3244
Earnings History > 0 > eps Difference
0.3244
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.17
Earnings History > 1 > eps Estimate
-0.32
Earnings History > 1 > eps Difference
0.15
Earnings History > 1 > surprise Percent
46.875
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.2501
Earnings History > 2 > eps Estimate
-0.2462
Earnings History > 2 > eps Difference
-0.0039
Earnings History > 2 > surprise Percent
-1.5841
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-29
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.29
Earnings History > 3 > eps Estimate
-0.2629
Earnings History > 3 > eps Difference
-0.0271
Earnings History > 3 > surprise Percent
-10.3081
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-11
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1988
Earnings History > 4 > eps Estimate
-0.24
Earnings History > 4 > eps Difference
0.0412
Earnings History > 4 > surprise Percent
17.1667
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.313
Earnings History > 5 > eps Estimate
-0.26
Earnings History > 5 > eps Difference
-0.053
Earnings History > 5 > surprise Percent
-20.3846
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.12
Earnings History > 6 > eps Estimate
-0.26
Earnings History > 6 > eps Difference
0.38
Earnings History > 6 > surprise Percent
146.1538
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-30
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.19
Earnings History > 7 > eps Estimate
-0.3
Earnings History > 7 > eps Difference
0.11
Earnings History > 7 > surprise Percent
36.6667
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-13
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.3
Earnings History > 8 > eps Estimate
-0.32
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
6.25
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.4
Earnings History > 9 > eps Estimate
-0.31
Earnings History > 9 > eps Difference
-0.09
Earnings History > 9 > surprise Percent
-29.0323
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.38
Earnings History > 10 > eps Estimate
-0.3
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-26.6667
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-28
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.2
Earnings History > 11 > eps Estimate
-0.36
Earnings History > 11 > eps Difference
0.16
Earnings History > 11 > surprise Percent
44.4444
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-13
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.49
Earnings History > 12 > eps Estimate
-0.39
Earnings History > 12 > eps Difference
-0.1
Earnings History > 12 > surprise Percent
-25.641
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.42
Earnings History > 13 > eps Estimate
-0.42
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-15
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.48
Earnings History > 14 > eps Estimate
-0.32
Earnings History > 14 > eps Difference
-0.16
Earnings History > 14 > surprise Percent
-50
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-06-28
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.27
Earnings History > 15 > eps Estimate
-0.32
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
15.625
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-14
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.41
Earnings History > 16 > eps Estimate
-0.25
Earnings History > 16 > eps Difference
-0.16
Earnings History > 16 > surprise Percent
-64
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.32
Earnings History > 17 > eps Estimate
-0.22
Earnings History > 17 > eps Difference
-0.1
Earnings History > 17 > surprise Percent
-45.4545
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-21
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.28
Earnings History > 18 > eps Estimate
-0.26
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-7.6923
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-20
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.37
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-22
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.01
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-19
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0151
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0151
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.2544
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.2544
Earnings History > 23 > surprise Percent
-
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInsider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $16,752,432.88 in Stock MarketBeat
Read more →Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $7,800,077.25 in Stock - MarketBeat
12/16/2025
Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $7,800,077.25 in Stock MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$24.5455
Analyst Picks
Strong Buy
6
Buy
3
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 81.16% of the total shares of Roivant Sciences Ltd
1.
SB INVESTMENT ADVISERS (UK) LTD(8.7794%)
since
2025/06/30
2.
FMR Inc(8.1287%)
since
2025/06/30
3.
Morgan Stanley - Brokerage Accounts(6.5449%)
since
2025/06/30
4.
BlackRock Inc(5.9038%)
since
2025/06/30
5.
Vanguard Group Inc(5.7589%)
since
2025/06/30
6.
Viking Global Investors LP(5.0137%)
since
2025/06/30
7.
Qvt Financial LP(4.3026%)
since
2025/06/30
8.
Fidelity Growth Compy Commingled Pl S(3.8307%)
since
2025/07/31
9.
Rubric Capital Management LP(2.983%)
since
2025/06/30
10.
State Street Corp(2.8956%)
since
2025/06/30
11.
Fidelity Growth Company Fund(2.8086%)
since
2025/07/31
12.
iShares Core S&P Mid-Cap ETF(2.0067%)
since
2025/08/31
13.
Vanguard Total Stock Mkt Idx Inv(1.9213%)
since
2025/07/31
14.
Patient Square Capital(1.8275%)
since
2025/06/30
15.
Two Seas Capital LP(1.552%)
since
2025/06/30
16.
Vanguard Small Cap Index(1.4499%)
since
2025/07/31
17.
Dimensional Fund Advisors, Inc.(1.1548%)
since
2025/06/30
18.
Geode Capital Management, LLC(1.135%)
since
2025/06/30
19.
SPDR® S&P Biotech ETF(1.056%)
since
2025/08/31
20.
Fidelity Growth Company K6(0.8314%)
since
2025/07/31
21.
Vanguard Small Cap Growth Index Inv(0.8159%)
since
2025/07/31
22.
UBS Group AG(0.7458%)
since
2025/06/30
23.
Fidelity Series Growth Company(0.7383%)
since
2025/07/31
24.
Anchorage Advisors, LLC(0.7077%)
since
2025/06/30
25.
BlackBarn Capital Partners LP(0.6773%)
since
2025/06/30
26.
Vanguard Institutional Extnd Mkt Idx Tr(0.6615%)
since
2025/07/31
27.
Bank of New York Mellon Corp(0.6599%)
since
2025/06/30
28.
MS INVF US Growth I(0.5909%)
since
2025/06/30
29.
Woodline Partners LP(0.5858%)
since
2025/06/30
30.
Whitefort Capital Management, LP.(0.5685%)
since
2025/06/30
31.
MS INVF US Advantage I(0.5527%)
since
2025/06/30
32.
Baker Bros Advisors LP(0.5517%)
since
2025/06/30
33.
Morgan Stanley Growth SMA(0.5249%)
since
2025/06/30
34.
Morgan Stanley Inst Growth I(0.5249%)
since
2025/06/30
35.
Morgan Stanley Growth(0.5249%)
since
2025/06/30
36.
SPDR® S&P MIDCAP 400 ETF Trust(0.4722%)
since
2025/07/31
37.
iShares Biotechnology ETF(0.3648%)
since
2025/08/31
38.
iShares S&P Mid-Cap 400 Growth ETF(0.3506%)
since
2025/08/31
39.
Fidelity Extended Market Index(0.3334%)
since
2025/07/31
40.
DFA US Small Cap I(0.3225%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.3244
Date
2025-09-30
EPS Actual
-0.17
EPS Estimate
-0.32
EPS Difference
0.15
Surprise Percent
46.875%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.